Skip to main content

Table 2 Clinicopathological characteristics of 70 patients aged ≥ 85 years who underwent ESD for gastric cancer

From: Prognostic nutritional index is an independent prognostic factor for older patients aged ≥ 85 years treated by gastric endoscopic submucosal dissection

Tumor type, n (%)  
 Initial lesion 64 (91.4)
 Metachronous lesion 6 (8.6)
Tumor location, n (%)  
 Upper 13 (18.6)
 Middle 23 (32.9)
 Lower 34 (48.6)
Tumor size, mm, median (range, IQR) 13.0 (4–95, 9.0)
Macroscopic appearance, n (%)  
 Elevated 40 (57.1)
 Depressed/flat 30 (42.9)
Histology, n (%)  
 Differentiated type 69 (98.6)
 Undifferentiated type 1 (1.4)
Depth, n (%)  
 M/SM1 67 (95.7)
 SM2 3 (4.3)
Lymphatic invasion, n (%) 4 (5.7)
Vascular invasion, n (%) 0 (0)
Ulcerative findings, n (%) 7 (10.0)
Curability n (%)  
 eCuraA 58 (82.9)
 eCuraB 4 (5.7)
 eCuraC-2 8 (11.4)
Additional gastrectomy, n (%) 0 (0)
Procedure time, min, median (range, IQR) 37.5 (6–415, 41)
Postoperative bleeding, n (%) 1 (1.4)
Perforation, n (%) 1 (1.4)
Other metachronous cancers, n (%) 0 (0)
Death due to any causes, n (%) 33 (47.1)
Death due to gastric cancer, n (%) 0 (0)
  1. ESD, endoscopic submucosal dissection; IQR, interquartile range; M, mucosa; SM1, superficial portion of the submucosa within 500 μm from the muscularis mucosae; SM2, deep portion of the submucosa ≥ 500 μm from the muscularis mucosae; min, minutes